Young American tourists' cause of death revealed after they were found 'motionless' at beach resort
Authorities previously identified the women as Kaoutar Naqqad, 23, Imane Mallah, 24, and Wafae El-Arar, 26, after they were found dead on Feb. 22 at the Royal Kahal Beach Resort in San Pedro.
Gian Cho, executive director of the National Forensics and Science Services (NFSS), told local outlet Love FM that test results "revealed that the three victims all had fatal exposure to carbon monoxide."
"So carbon monoxide … has been revealed as the contributing or the underlying exposure that led to the acute pulmonary edema, which was the final cause of death," Cho said. "We did a very complete and comprehensive toxicology screening on the blood and liver tissues from these victims so that we can give the family a conclusive answer and closure as to what contributed to their death."
Young American Tourists Found Dead At Caribbean Resort; Authorities Investigating
Cho added that officials tested for drugs in their systems, as well as "hundreds of different possible chemicals or poisons that they may have been exposed to."
Read On The Fox News App
"Again … there were no illicit drugs found in toxicology results. The only thing that was at high or significant levels were the carbon monoxide levels," he told Love FM.
Popular Spring Break Activity Lands American Tourist In Hospital: 'Felt Like I Was In A Car Accident'
Chester Williams, police commissioner, told Love FM that after the Americans' bodies were found in their room, officials tested the room for carbon monoxide, and the test came back negative.
"Nonetheless, following information we have gotten through the U.S. Embassy…supported by persons who were at the room before, indicating that they had used their own carbon monoxide tester and detected carbon monoxide in one of the rooms," Williams said.
He suggested that the hotel rooms have heaters that are powered by gas, so carbon monoxide might only be detected when the heaters are turned on for several hours and possibly undetectable when they are turned off for an extended period of time.
Florida Spring Break Crowd Kicked Off Beach Amid State's Crackdown On Partiers
Hotel staff apparently attempted to contact the group the Friday before they were found. Resort employees used a master key to enter the room Saturday morning, where the women were found "motionless," according to The Associated Press.
Fox News Digital reached out to the resort.
The victims' families shared a joint statement on social media, saying the three women were "each a beloved light in the world lost too soon."
Photos: Spring Breakers Flock To Florida Beaches For Sun And Sand
"Our families and all who loved these women are shattered, struggling to comprehend this profound and sudden loss," their families said. "With this statement, our families hope to honor Kaoutar, Imane and Wafae by telling the world about the girls we knew and loved."
They went on to describe Mallah as a "radiant spirit, and a beacon of kindness."
"She embraced life wholeheartedly, cherishing every soul that shared the journey with her," the statement reads.
Naqqad's "kindness and warmth touched everyone she met."
"She was compassionate, caring, and deeply devoted to those she loved. Her heart was full of generosity, always putting others before herself and offering a listening ear, a comforting word, and unwavering support," the statement says.
El-Arar "was full of life, dreams, and unwavering faith."
"Her name, meaning faithfulness and loyalty, was a true reflection of who she was — honest, kind, and deeply devoted to the people she loved. Wafaewas a bright mind with a passion for women's health," her family said.Original article source: Young American tourists' cause of death revealed after they were found 'motionless' at beach resort
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Hill
23 minutes ago
- The Hill
Novo Nordisk, GoodRx selling Ozempic at half cost for customers paying cash
Novo Nordisk and GoodRx announced a partnership this week to sell products Ozempic and Wegovy at half their normal cost to patients who pay for the medications with cash. Starting this week, customers will be able to buy a month's supply of Novo Nordisk's semaglutide pen products for $499 through GoodRx. The list price for a monthly supply of a product like Ozempic is normally around $1,000 or more without insurance. 'Demand for GLP-1 medications is at an all-time high, but too many Americans still face barriers accessing them,' GoodRx CEO and President Wendy Barnes said in a statement. 'By partnering with Novo Nordisk, we're taking a significant step forward in making these innovative brand-name treatments more accessible for millions of people who need them,' added Barnes. 'It's a powerful example of how the GoodRx platform can deliver savings at scale—bridging gaps in coverage and ensuring more people can get the care they deserve.' This is the most recent in similar moves Novo Nordisk has made to make its popular diabetes and weight loss medication more widely available. Earlier this year, the company announced a direct-to-patient program called NovoCare® Pharmacy for uninsured and underinsured individuals who can pay $499 a month for Wegovy. Novo Nordisk also partnered with online telehealth companies like Ro and LifeMD to sell its pens at the same price point. The telehealth company Hims & Hers was also originally included in the partnership, but Novo Nordisk ended it after accusing the company of illegally selling compounded versions of semaglutide. Hims & Hers maintains it is providing personalized, compounded products within regulatory guidelines. 'Improving access to effective FDA-approved treatment is central to our mission, and our collaboration with GoodRx allows us to reach those who seek savings and support from their trusted and established platform,' Dave Moore, executive vice president of U.S. operations of Novo Nordisk, said in a statement. 'This initiative enables us to meet GoodRx patients where they are with our authentic GLP-1 medicines in addition to supporting the launch of the new Ozempic® self-pay offer for type 2 diabetes patients at an unprecedented price.' Sen. Bernie Sanders (I-Vt.), a prominent critic of high drug costs, called the announcement a 'modest step forward.' 'Novo Nordisk's move to cut the price of Ozempic to $499 for the uninsured is a modest step forward, but let's not forget,' Sanders said on the social media platform X. 'Ozempic costs just $59 in Germany while it costs less than $5 to make. The U.S. must no longer pay the highest prices in the world for prescription drugs.
Buzz Feed
an hour ago
- Buzz Feed
FDA Warns Public On Radioactive Walmart Shrimp
If you love eating shrimp, you might want to take a seat for what I'm about to tell you. ABC News reports that the FDA is warning the general American public not to eat, sell, or serve certain types of Great Value raw frozen shrimp sold at Walmart — because it may be radioactive. Yes, really. How did we get here? Well, according to an FDA press release, the shrimp in question "appears to have been prepared, packed, or held under insanitary conditions whereby it may have become contaminated with Cs-137 and may pose a safety concern." Cs-137, if you're not a dang chemist, is short for Cesium-137, a radioactive isotope. If you want to know whether your shrimp is safe, you can head here to get all the details. But let's face it — you're here for the jokes people are making online, and there are more of them than there are shrimp in the sea: Stay safe out there, shellfish fiends...
Los Angeles Times
an hour ago
- Los Angeles Times
U.S. pediatricians' new COVID-19 vaccine recommendations differ from CDC advice
NEW YORK — For the first time in 30 years, the American Academy of Pediatrics is substantially diverging from U.S. government vaccine recommendations. The group's new COVID-19 recommendations — released Tuesday — come amid a tumultuous year for public health, as vaccine skeptics have come into power in the new Trump administration and government guidance has become increasingly confusing. This isn't going to help, acknowledged Dr. James Campbell, vice chair of the AAP infectious diseases committee. 'It is going to be somewhat confusing. But our opinion is we need to make the right choices for children to protect them,' he added. The AAP is strongly recommending COVID-19 shots for children ages 6 months to 2 years. Shots also are advised for older children if parents want their kids vaccinated, the AAP said. That differs from guidance established under U.S. Health Secretary Robert F. Kennedy Jr., which doesn't recommend the shots for healthy children of any age but says kids may get the shots in consultation with physicians. Children ages 6 months to 2 years are at high risk for severe illness from COVID-19, and it was important that recommendations continue to emphasize the need for them to get vaccinated, said Campbell, a University of Maryland infectious diseases expert. Vaccinations also are recommended for older children who have chronic lung diseases or other conditions that put them at higher risk for severe disease, the AAP said. In a statement, Department of Health and Human Services spokesperson Andrew Nixon said 'the AAP is undermining national immunization policymaking with baseless political attacks.' He accused the group of putting commercial interests ahead of public health, noting that vaccine manufacturers have been donors to the AAP's Friends of Children Fund. The fund is currently paying for projects on a range of topics, including health equity and prevention of injuries and deaths from firearms. The 95-year-old Itasca, Illinois-based organization has issued vaccination recommendations for children since the 1930s. In 1995, it synced its advice with recommendations made by the federal government's Centers for Disease Control and Prevention. There have been a few small differences between AAP and CDC recommendations since then. For example, the AAP has advised that children get HPV vaccinations starting at age 9; the CDC says that's OK but has emphasized vaccinations at ages 11 and 12. But in 30 years, this is the first time the recommendations have differed 'in a significant or substantial way,' Campbell said. Until recently, the CDC — following recommendations by infectious disease experts — has been urging annual COVID-19 boosters for all Americans ages 6 months and older. But in May, U.S. Health Secretary Robert F. Kennedy Jr. announced that COVID-19 vaccines are no longer recommended for healthy children and pregnant women. A few days later, the CDC issued language that healthy children may get the shots, but that there was no longer a 'should' recommendation. The idea that healthy older kids may be able to skip COVID-19 boosters has been brewing for some time among public health experts. As the COVID-19 pandemic has waned, experts have increasingly discussed the possibility of focusing vaccination efforts on people 65 and older — who are among those most as risk for death and hospitalization. A CDC expert panel in June was set to make recommendations about the fall shots. Among the options the panel was considering was whether suggest shots for high-risk groups but still giving lower-risk people the choice to get vaccinated. But Kennedy bypassed the group, and also decided to dismiss the 17-member panel and appoint his own, smaller panel, that included vaccine skeptics. Kennedy also later excluded the AAP, the American Medical Association and other top medical organizations from working with the advisers to establish vaccination recommendations. Kennedy's new vaccine panel has yet to vote on COVID-19 shot recommendations. The panel did endorse continuing to recommend fall flu vaccinations, but also made a decision that led to another notable difference with the AAP. The new advisory panel voted that people should only get flu vaccines that are packaged as single doses and do not contain the preservative thimerosal. The AAP said there is no evidence of harm from the preservative, and recommended doctors use any licensed flu vaccine product that's appropriate for the patient. Stobbe writes for the Associated Press. The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Science and Educational Media Group and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.
